Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 10:24 PM ET

Healthcare Equipment and Supplies

Company Overview of Daktari Diagnostics, Inc.

Company Overview

Daktari Diagnostics, Inc. develops point-of-care diagnostic systems for global health applications. It develops Daktari CD4, a portable CD4 cell counting system that analyzes small volumes of blood or other fluids in various types of health care settings to deliver diagnostic test results to clinicians and patients across the globe. The company was founded in 2008 and is based in Cambridge, Massachusetts.

85 Bolton Street

Cambridge, MA 02140

United States

Founded in 2008





Key Executives for Daktari Diagnostics, Inc.

Chief Executive Officer, President and Director
Vice President of Finance
Vice President of Product Design and Development
Vice President of Quality & Regulatory
Vice President of Assay & R&D
Compensation as of Fiscal Year 2015.

Daktari Diagnostics, Inc. Key Developments

Daktari Diagnostics Appoints Donald B. Hawthorne as President & Chief Executive Officer and Member of the Board of Directors

Daktari Diagnostics announced the appointment of Donald B. Hawthorne as President & Chief Executive Officer (CEO), and member of the Board of Directors. Mr. Hawthorne brings over 30 years of life sciences industry experience, most recently as President & CEO of AdvanDx.

Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus

Daktari Diagnostics announced a collaboration with Merck, known as MSD outside the United States and Canada, to develop Daktari's rapid hepatitis C virus (HCV) screening test. The deal, worth up to $8.5 million over the next 3.5 years, will support an accelerated development timeline for the clinical validation and regulatory approval of Daktari's HCV test. The Daktari technology forms the basis for a point-of-care instrument that can detect low levels of virus directly in a single drop of blood in approximately 30 minutes, making on-the-spot HCV treatment decisions possible. The Daktari test is based on high-sensitivity measurement of the HCV core antigen, which is used in Europe and Japan for the diagnosis of chronic hepatitis C infection, but has never been available as a point-of-care diagnostic. The Daktari System includes an embedded connectivity platform, Daktari InSight, which provides real-time data management through mobile network connectivity and a web-based dashboard, allowing rapid monitoring of test results. The Daktari System has the potential to transform public health screening programs and be made available at retail clinics, pharmacies, and doctor's offices.

The National Institute of Health Awards Daktari Diagnostics with $1.2 Million Grant for Phase II Small Business Innovation Research

The National Institute of Health has awarded a Phase II Small Business Innovation Research (SBIR) grant to Daktari Diagnostics for development of a point-of-care hepatitis C diagnostic, following onto the Phase I grant awarded in June 2014 as part of the NIH SBIR Fast Track program. The Phase II grant, for $1.2 million, funds efforts in antibody science and microfluidics engineering to make the hepatitis C virus (HCV) viral load test fast and portable, enabling it to impact care in remote areas.

Similar Private Companies By Industry

Company Name Region
MedivoxRx Technologies Inc United States
SENSUS Healthcare LLC United States
NormaTec Industries, LP United States
Avant Medical Corporation United States
InnovaQuartz LLC United States

Recent Private Companies Transactions

Private Placement
March 2, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Daktari Diagnostics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at